JMP Securities Assumes Ocular Therapeutix (OCUL) at Market Outperform
Tweet Send to a Friend
JMP Securities analyst Jonathan Wolleben assumes coverage on Ocular Therapeutix (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
